Efung Capital (HK) Management Limited
efungcapital.com Direct investor
Efung Capital is a Chinese investment firm focused on global biopharmaceutical VC/PE investments. It has invested in a range of domestic and overseas healthcare and life sciences companies.
Efung Capital (HK) Management Limited is a venture capital firm headquartered in Shenzhen, China, founded in 2012. It invests directly in companies, in biopharma, healthcare, medical devices and life sciences.
“专注于全球生物医药VC/PE投资，深度筛选并投资了微芯生物、禾元生物、前沿生物、亚盛医药、普门科技、和铂医药、和元生物、北芯生命、亚虹医药、思路迪医药、真实生物、Apexigen、Centrexion和Elicio等境内外优质企业。”
— Efung Capital (HK) Management Limited, own website
- Layer
- Direct investor
- Type
- Venture capital
- Stage
- Not stated
- Invests in
- global, China, US
- Sectors
- biopharma, healthcare, medical devices, life sciences
- Founded
- 2012
Where this comes from
Every fact above was read from a page Efung Capital (HK) Management Limited publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- https://www.efungcapital.com/name, is_investor, layer, type, hq_country, hq_city, invests_in_geographies, sectors, thesis_quote, thesis_quote_page, description, founded, status, confidence
Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.
Record 12644 · added 2026-09-29 · link last verified 2026-09-29 · confidence high
Similar investors
- BioVeda China Fund (BVCF)Venture capital · Shanghai, China
- Redhill CapitalVenture capital · Guangzhou, China
- Zhejiang Kefa Capital Management Co., Ltd.Venture capital · Pre-seed – Growth · Hangzhou, China
- Addor CapitalVenture capital · Seed – Buyout · Nanjing, China
- Kaitai CapitalVenture capital · Hangzhou, China
- Long Hill CapitalVenture capital · China